Jonathan J Stillo

Should we still do #DOT for #TB? My article is now out in Human Organization. Here is the open access link: tandfonline.com/doi/full/10.10… (thanks to @WayneStateCLAS @AnthroAtWayne & @waynestate OVPR for support) @SfAAnthro @sshiftb @TBECoalition @StopTBUSA @TAGTeam_Tweets @StopTB

Happening right now: Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) ucsf.zoom.us/j/94018665760?… #tb @StopTBUSA @TBFighters @realTBpeople @TBECoalition

Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) Registration Deadline: Tuesday, May 6th, 2025 Register here: currytbcenter.ucsf.edu/trainings/high… @StopTB #tb @TheUnion_TBLH @realTBpeople

"Our public health infrastructure is fragile, understaffed and under-resourced,” Stillo said. And public health infrastructure is key to preventing TB-related disaster." @StopTBUSA @TAGTeam_Tweets @AnthroAtWayne @We_Are_TB @WayneStateCLAS salon.com/2025/02/21/tub…

Note our TIME CHANGE! Our Annual Membership Meeting will happen on Friday, February 28th at 5:00pm Pacific and 8:00pm Eastern Time. We can't wait to see you there!! #endtb #stoptb #stoptbnow

The deadline for collection of candidate's applications for joining the TBEC Board is extended till 26th December 2024! More information ➡️ tbcoalition.eu/news/nominatio…

XDR #TB is a #GlobalHealth emergency. Clinicians, affected community, and other experts have come together to create a field guide for managing TB with expanded resistance. Please share widely. @TAGTeam_Tweets @TBECoalition @StopTBUSA tbcenter.jhu.edu/wp-content/upl…

Delamanid is now part of WHO-recommended short-course DR-TB regimens, so access is more urgent than ever. Recent price ⬇️ is good step, but doesn't go far enough! We've fought for delamanid access for years (see pics!) + will continue. 1/4/6x24 statement: treatmentactiongroup.org/statement/1-4-…

MSF Calls for Equitable Access to TB Drugs and Diagnostics in First-Ever Plenary Session on Access at the TB Union Conference globaltbcab.org/tb-news/msf-ca…

People w/ extensively drug-resistant TB have the fewest treatment options. Addressing their needs reimagining pre-approval access mechanisms, urges a growing consensus of researchers + TB survivors. New statement from the TB CAB: globaltbcab.org/statement/pre-…

Amazing findings! Debrah Vambe sharing findings @UnionConference from Eswatini highlights profound gaps in existing diagnostic algorithms that potentially miss Bdq resistance (and clofazimine) among diagnosed INH-or MDRTB-resistant! This data is from 2021-2022!!

Critical insights being shared right now by Paran - a TB survivor and brilliant speaker @UnionConference! She asks us all: We don’t have longer regimens, and no injectables for a majority of #MDRTB patients … but what is our plan B if the shorter regimens fail?

@dranuragb @dr_madhavib @_drmeherajay @yu_cns Congratulations, Anurag! Well-deserved. This is incredibly important research.

I dedicate this award to the RATIONS team that worked non-stop during the COVID despite challenges, the rural and tribal communities who taught us humanity and stoicism in the face of grave adversity. @dr_madhavib @_drmeherajay @yu_cns and strong field team of 60+ TB warriors

For future medical tools, we want countries and donors to start attaching access requirements to public funding that is given for R&D. Only then can we guarantee access and affordability of tests and treatments. @Christo51566018 #UnionConf2024 @MSF_access msfaccess.org/msf-calls-equi…

A message for Pharmaceutical Corporations Otsuka and Viatris- Make Delamanid Affordable Now! Price of this drug still remains high at $1100 by Otsuka and $800 by Viatris. If we really want to see wider scale up and save lives of people, price need to go down.

Let us share with you a publication "Building social equity and person-centred innovation into the end TB response" - ingentaconnect.com/content/iuatld…, which addresses a social science perspective on equity and the TB response.

"60% of LICs and 25% of MICs are in debt stress, 3.3 B people live in countries that spend more on interest payments than on education or health. Urgent #debtrelief and restructuring is needed to free up fiscal space for health." - @doctorsoumya @UnionConference #Unionconf2024

@StopTBUSA Congratulations, Alina and Aishva!

More than 70 TB activists from around the world called on @DanaherCorp and @CepheidNews at the @UnionConference to make all GeneXpert cartridges affordable for all and also to open their books and share the audit.